Head of Clinical Science & Strategy — Precision Oncology

About the Role

This role serves as the scientific and clinical backbone of one of our flagship AI-based SaMD (Software as a Medical Device) product lines in the breast cancer space. It is a lifecycle position spanning evidence generation, KOL engagement, and clinical deployment support. The Director will be the primary interface between Waiv's internal Medical team and the external scientific community, playing a critical role in establishing the scientific credibility and clinical adoption of our tools.

Product Lifecycle — Medical Leadership

• Own the end-to-end medical strategy for the assigned breast cancer AI-based prognostic solution, from evidence generation through clinical adoption — in coordination with the VP of Medical Affairs
• Drive the scientific narrative: translate clinical data into compelling, rigorous medical communications for internal and external audiences
• Evaluate emerging scientific trends, competitive intelligence, and evolving standards of care to inform product positioning, portfolio prioritisation, and lifecycle management
• Contribute to product strategy regarding claims development and regulatory submissions in partnership with RAQA, Product, and Clinical Affairs

Clinical Evidence Generation

• Co-develop and review study protocols and clinical study reports for prospective and retrospective validation studies
• Contribute medical perspective to abstract and manuscript preparation; coordinate author relationships and publication planning
• Interface with internal teams and external partners to ensure medical accuracy of analytical outputs
• Support identification and prioritisation of data cuts for major oncology congresses
• Support evidence generation for market access strategy and build data packages for payers

KOL Engagement & Scientific Exchange

• Build and maintain high-value relationships with breast oncologists, pathologists, and surgeons across North America and Europe
• Serve as the scientific face of Waiv at key congresses and symposia; deliver medical education and facilitate advisory boards
• Identify clinical champions and research collaborators — including cooperative groups, academic institutions, and healthcare systems — for clinical validation interventional trials; co-develop investigator-initiated research frameworks
• Gather and synthesise field-based medical insights; systematically feed clinical intelligence back into Product, Portfolio, and R&D strategy

Cross-functional Collaboration

• Collaborate closely with: Medical Affairs, Commercial, VP Pathology, Market Access, R&D/Biostatistics, and Marketing
• Contribute to board-level and investor-facing scientific communications as required
• Support Medical Affairs team capacity and knowledge-sharing on breast cancer science and medical device regulatory context

Scientific & Clinical Background

• Advanced degree required: MD, PharmD, or PhD in a relevant biomedical discipline (oncology, pathology, translational medicine, or similar)
• Deep expertise in breast cancer biology, clinical practice, and treatment decision-making
• Strong command of prognostic and predictive biomarker methodology
• Comfort with quantitative oncology data analysis and interpretation: biostatistics, survival analysis, biomarker validation methodology, and data interpretation

Medical Affairs & Industry Experience

• Minimum 8–10 years of Medical Affairs, MSL, or clinical/scientific leadership experience in oncology, ideally in a precision medicine context
• Demonstrated experience managing or co-developing clinical evidence programs (observational studies, registries, prospective studies)
• Hands-on KOL engagement and publication experience; ability to lead advisory boards and represent the company at international congresses
• Familiarity with precision medicine, genomic testing regulatory and clinical frameworks (FDA/EMA guidance) is strongly preferred

Operational & Cross-cultural Skills

• Self-starter with high autonomy; comfortable in a lean, fast-paced environment typical of a growth-stage medtech company
• Excellent scientific communication skills — written (publications, regulatory documents, slide decks) and verbal (advisory boards, congresses)
• Willingness to travel internationally; estimated travel expected for congresses, KOL meetings, and site visits across North America and Europe